These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7460191)

  • 1. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse.
    Dorr RT; Alberts DS; Chen HS
    Cancer Chemother Pharmacol; 1980; 5(1):17-20. PubMed ID: 7460191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of adriamycin skin necrosis: an experimental study.
    Cohen MH
    Cancer Treat Rep; 1979 Jun; 63(6):1003-4. PubMed ID: 466641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse.
    Dorr RT; Alberts DS
    J Natl Cancer Inst; 1985 Jan; 74(1):113-20. PubMed ID: 3855472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental model of doxorubicin extravasation in the mouse.
    Dorr RT; Alberts DS; Chen HS
    J Pharmacol Methods; 1980 Nov; 4(3):237-50. PubMed ID: 7442269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of doxorubicin-induced skin necrosis in mice by butylated hydroxytoluene.
    Daugherty JP; Khurana A
    Cancer Chemother Pharmacol; 1985; 14(3):243-6. PubMed ID: 3995685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisantrene solubility and skin toxicity studies: efficacy of sodium bicarbonate as a local ulceration antidote.
    Dorr RT; Peng YM; Alberts DS
    Invest New Drugs; 1984; 2(4):351-7. PubMed ID: 6096286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds.
    Dorr RT; Alberts DS
    Cancer Treat Rep; 1981; 65(11-12):1001-6. PubMed ID: 7296547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antioxidants and hyperbaric oxygen in ameliorating experimental doxorubicin skin toxicity in the rat.
    Upton PG; Yamaguchi KT; Myers S; Kidwell TP; Anderson RJ
    Cancer Treat Rep; 1986 Apr; 70(4):503-7. PubMed ID: 3009011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of antidotes for extravasation injury produced by 6-hydroxymethylacylfulvene (MGI 114), a novel cytotoxic antitumor agent, in an intradermal toxicity model in rats.
    Marshall RF; Arthaud LE; MacDonald JR
    Cancer Chemother Pharmacol; 2000; 45(5):397-401. PubMed ID: 10803923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse.
    Dorr RT; Alberts DS
    Cancer Treat Rep; 1983 May; 67(5):499-501. PubMed ID: 6850665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin ulceration potential of paclitaxel in a mouse skin model in vivo.
    Dorr RT; Snead K; Liddil JD
    Cancer; 1996 Jul; 78(1):152-6. PubMed ID: 8646711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of sodium thiosulfate as a local antidote to mechlorethamine skin toxicity in the mouse.
    Dorr RT; Soble M; Alberts DS
    Cancer Chemother Pharmacol; 1988; 22(4):299-302. PubMed ID: 3168143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of experimental doxorubicin skin toxicity by beta-adrenergic compounds.
    Dorr RT; Alberts DS
    Cancer Res; 1981 Jun; 41(6):2428-32. PubMed ID: 7237439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of adriamycin-induced full-thickness skin loss using hyaluronidase infiltration.
    Disa JJ; Chang RR; Mucci SJ; Goldberg NH
    Plast Reconstr Surg; 1998 Feb; 101(2):370-4. PubMed ID: 9462769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment options in extravasation injury: an experimental study in rats.
    Yilmaz M; Demirdover C; Mola F
    Plast Reconstr Surg; 2002 Jun; 109(7):2418-23. PubMed ID: 12045569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin and perivascular toxicity induced experimentally by doxorubicin.
    Balsari A; Lombardo N; Ghione M
    J Chemother; 1989 Oct; 1(5):324-9. PubMed ID: 2585034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histopathogenesis of skin and subcutaneous injury induced by adriamycin.
    Luedke DW; Kennedy PS; Rietschel RL
    Plast Reconstr Surg; 1979 Apr; 63(4):463-5. PubMed ID: 424456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
    Dorr RT; Alberts DS; Einspahr J; Mason-Liddil N; Soble M
    Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of tissue necrosis due to accidental extravasation of cytostatic drugs by a conservative approach.
    Tsavaris NB; Komitsopoulou P; Karagiaouris P; Loukatou P; Tzannou I; Mylonakis N; Kosmidis P
    Cancer Chemother Pharmacol; 1992; 30(4):330-3. PubMed ID: 1643703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of sodium bicarbonate as a means of ameliorating doxorubicin-induced dermal necrosis in rats.
    Bartkowski-Dodds L; Daniels JR
    Cancer Chemother Pharmacol; 1980; 4(3):179-81. PubMed ID: 6249515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.